Searchable abstracts of presentations at key conferences in endocrinology

ea0098p7 | Population Science | NANETS2023

Validity of geographic-level social determinant of health metrics in pancreatic neuroendocrine tumors

Gillis Andrea , Herring Brendon , Guenter Rachael , Chen Weisheng , Chen Dai , Chen Herbert , Bart Rose J. , Manne Upender , Bhatia Smita

Background: Various social determinant of health (SDOH) metrics and indices are utilized to evaluate access to cancer care and to explain disparities in outcome in pancreatic neuroendocrine tumors (PNETs). Little prior work has compared the validity of various geographic metrics. Therefore we aimed to examine different geographic metrics validity (from smallest to largest: census block group< census tract< zip code< county) utilizing single institutional data in a ...

ea0098p8 | Population Science | NANETS2023

Influence of social determinants of health on pancreatic neuroendocrine tumor stage at presentation

Gillis Andrea , Herring Brendon , Guenter Rachael , Chen Weisheng , Chen Dai , Chen Herbert , Bart Rose J. , Manne Upender , Bhatia Smita

Background: Tumor size and lymph node involvement (stage) have been utilized to prognosticate pancreatic neuroendocrine tumors (PNETs) but the influence of race and social vulnerability on these factors remains unexplored. Therefore we sought to explore this in a racially and socioeconomically diverse cohort.Methods: We reviewed records of all patients who underwent surgical resection for PNETs from 2006-2022 at a single NCI-designated cancer center in t...

ea0013s6biog | Clinical Endocrinology Trust Visiting Professor Lecture | SFEBES2007

Clinical Endocrinology Trust Visiting Professor Lecture

Dunaif Andrea

Andrea Dunaif, Northwestern University, Feinberg School of Medicine, Chicago, United States. AbstractDr Dunaif received her MD from Columbia University College of Physicians and Surgeons, trained in New York and Boston and rose to rank of Associate Professor at the Mount Sinai School of Medicine. Since 1992 Dr Dunaif has held posts at Brigham and Women’s Hospital as Director of Women’s Health and Chief of the...

ea0063s3.2 | Circadian clocks: from pathophysiology to chronomedicine | ECE2019

Fixing the broken clock in adrenal disorders

Isidori Andrea

Context: Glucocorticoids (GC) mediate some of the adverse health-related consequences of circadian misalignment, such occurs in shift workers who have an increased cardio-metabolic, immune and cancer risk. Investigating the effect of circadian cortisol exposure in patients with GC excess and defect is crucial. In a therapeutic perspective large attention has been given to the total daily GC exposure, much less to the timing-of-the-day relative exposure. Clock genes are essenti...

ea0063s15.2 | European Young Endocrine Scientists (EYES) | ECE2019

Investigating glucocorticoid excess as mediators of bone marrow adiposity expansion during caloric restriction

Lovdel Andrea

Background: Bone marrow adipose tissue (BMAT) comprises >10% of total adipose mass in healthy humans and further increases during caloric restriction (CR). However, BMAT function during CR and other conditions remains poorly understood. Circulating glucocorticoids also increase during CR, and glucocorticoid therapy increases BMAT; thus, we hypothesise that glucocorticoid excess mediates BMAT expansion during CR. Many effects of endogenous glucocor...

ea0063s18.2 | Congenital hypogonadotropic hypogonadism: New insights into GnRH Regulation | ECE2019

Flipping the GnRH switch with microRNAs

Messina Andrea

A sparse population of a few hundred primarily hypothalamic neurons forms the hub of a complex neuroglial network that controls reproduction in mammals by secreting the ‘master molecule’, gonadotropin-releasing hormone (GnRH). Both the Kisspeptin input on GnRH neurons and timely changes in GnRH expression are necessary for the onset of puberty. However, the exact molecular mechanisms underlying this process remain elusive. Here, we report that a dramatic inversion in...

ea0041d1.3 | The use of NSAIDs in endocrine cancers: the case of Celecoxib | ECE2016

The use of NSAIDs in endocrine cancers: the case of Celecoxib AGAINST

Sacchetti Andrea

The antitumor properties of non-steroidal anti-inflammatory drugs (NSAIDs), with respect to both cancer prevention and therapy, have raised considerable interest in the last two decades, leading to well consolidated evidences in gastrointestinal cancers, especially colorectal cancer. NSAID action has been proposed to occur through two independent modes: a COX-dependent one, mainly involving the inhibition of COX-2-mediated PGE2 production, and a COX-independent one, mainly inv...

ea0070pl7 | Effects of EDCs on neuro-endocrine systems and behaviour | ECE2020

Endocrine disruption of neuroendocrine development, function, and behavior

Gore Andrea

Environmental endocrine-disrupting chemicals (EDCs) are exogenous chemicals that perturb hormones and their actions. Exposures to EDCs during critical periods of life, especially in the developing fetus and infant, are particularly problematic due to the high sensitivity of the perinatal hypothalamus to endogenous hormones and exogenous compounds. Our lab has been using a rat model of prenatal exposure to two classes of EDCs: a polychlorinated biphenyl (PCB) mixture used previ...

ea0022s7.3 | Approaches to preservation of gonadal function after cancer therapy | ECE2010

Oocyte cryopreservation

Borini Andrea

IVF treatment would gain considerable advantage from a safe and efficient oocyte cryopreservation method. Embryo freezing, which involves important legal and ethical drawbacks, would be no longer needed. Women facing a destiny of premature ovarian failure or requiring oocyte donation would also benefit from oocyte cryopreservation. Studies conducted in the last few years suggest that oocyte cryopreservation can be applied in a systematic and reproducible fashion, in some cases...

ea0014s11.3 | Polycystic ovary syndrome | ECE2007

Hyperandrogenism and metabolic syndrome (MBS) in polycystic ovary syndrome (PCOS)

Dunaif Andrea

PCOS is a complex genetic disease resulting from the interplay between susceptibility genes and environmental factors. The syndrome is characterized by hyperandrogenism, disordered gonadotropin secretion, profound insulin resistance and, frequently, obesity. It is a leading risk factor for type 2 diabetes mellitus and MBS in adolescent and young adult women. In PCOS, MBS risk increases with increasing androgen levels, independent of insulin resistance and obesity, and antagoni...